Brief: Immix Biopharma Announces Strategic Investment By Houston Based Goose Capital, Led By Founding Member Dr. Nancy T. Chang
08/09/2025 21:42
Sept 8 (Reuters) - Immix Biopharma Inc IMMX.O: IMMIX BIOPHARMA ANNOUNCES STRATEGIC INVESTMENT BY HOUSTON BASED GOOSE CAPITAL, LED BY FOUNDING MEMBER DR. NANCY T. CHANG Source text: ID:nGNX8f4hgC Further company coverage: IMMX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary